Country Profile

Togo

Togo is an emerging destination for Indian pharmaceutical exports — $30.2M in FY 2025–26, with 3.0× growth over the past decade. Medicines accounts for 65% of shipments, with vaccines contributing $4.48M. The compound annual growth rate since FY2015 stands at 10.6%.

🇹🇬 $30.2M · 3.0× growth since FY2015 · 10.6% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$30.2M
Exports FY2025–26 DGCIS
3.0×
Growth FY2015→2026
10.6%
CAGR FY2015→2026
65%
Medicines Share
5
Product Categories Supplied
Togo is an emerging destination for Indian pharmaceutical exports — $30.2M in FY 2025–26, with 3.0× growth over the past decade. Medicines accounts for 65% of shipments, with vaccines contributing $4.48M. The compound annual growth rate since FY2015 stands at 10.6%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $19.6M (64.8%) Medicine Ingredients $5.79M (19.2%) Vaccines $4.48M (14.8%) Surgical & Hospital Supplies $223K (0.7%) Traditional & Herbal $154K (0.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Togo in the RBI overseas direct investment dataset (2011–2026).